These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 33563906)

  • 1. A clinical perspective on plasma cell leukemia; current status and future directions.
    Tuazon SA; Holmberg LA; Nadeem O; Richardson PG
    Blood Cancer J; 2021 Feb; 11(2):23. PubMed ID: 33563906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary plasma cell leukemia 2.0: advances in biology and clinical management.
    Neri A; Todoerti K; Lionetti M; Simeon V; Barbieri M; Nozza F; Vona G; Pompa A; Baldini L; Musto P
    Expert Rev Hematol; 2016 Nov; 9(11):1063-1073. PubMed ID: 27759436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents.
    Mina R; Joseph NS; Kaufman JL; Gupta VA; Heffner LT; Hofmeister CC; Boise LH; Dhodapkar MV; Gleason C; Nooka AK; Lonial S
    Cancer; 2019 Feb; 125(3):416-423. PubMed ID: 30332496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Plasma Cell Leukemia: Identity Card 2016.
    Musto P; Simeon V; Todoerti K; Neri A
    Curr Treat Options Oncol; 2016 Apr; 17(4):19. PubMed ID: 26995215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Plasma cell leukemia: a highly aggressive monoclonal gammopathy with a very poor prognosis].
    Jurczyszyn A; Zawirska D; Skotnicki AB
    Przegl Lek; 2011; 68(6):320-5. PubMed ID: 22039670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An update on biology, diagnosis and treatment of primary plasma cell leukemia.
    Musto P; Statuto T; Valvano L; Grieco V; Nozza F; Vona G; Bochicchio GB; La Rocca F; D'Auria F
    Expert Rev Hematol; 2019 Apr; 12(4):245-253. PubMed ID: 30905220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic advances in the treatment of primary plasma cell leukemia: a focus on hematopoietic cell transplantation.
    Nishihori T; Abu Kar SM; Baz R; Alsina M; Harousseau JL; Kharfan-Dabaja MA
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1144-51. PubMed ID: 23416092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in the Diagnosis and Therapy of Primary Plasma Cell Leukemia -Review].
    Wang H; Li JY; Sun C; Zhou X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec; 25(6):1837-1841. PubMed ID: 29262927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical characteristics and prognosis of patients with primary plasma cell leukemia (pPCL) according to the new IMWG definition criteria.
    Yan W; Fan H; Xu J; Liu J; Li L; Du C; Deng S; Sui W; Hao M; Yi S; Zou D; Qiu L; Xu Y; An G
    Leuk Lymphoma; 2022 Dec; 63(12):2955-2964. PubMed ID: 35819882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How We Manage Newly Diagnosed Multiple Myeloma With Circulating Tumor Cells.
    van de Donk NWCJ
    J Clin Oncol; 2023 Mar; 41(7):1342-1349. PubMed ID: 36450104
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Characteristics and Outcomes of Patients With Primary Plasma Cell Leukemia in the Era of Novel Agent Therapy.
    Nandakumar B; Kumar SK; Dispenzieri A; Buadi FK; Dingli D; Lacy MQ; Hayman SR; Kapoor P; Leung N; Fonder A; Hobbs M; Hwa YL; Muchtar E; Warsame R; Kourelis TV; Russell S; Lust JA; Lin Y; Siddiqui M; Go RS; Jevremovic D; Kyle RA; Gertz MA; Rajkumar SV; Gonsalves WI
    Mayo Clin Proc; 2021 Mar; 96(3):677-687. PubMed ID: 33673918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary plasma cell leukaemia in a 39-year-old man.
    Kasinathan G
    BMJ Case Rep; 2020 Jul; 13(7):. PubMed ID: 32709663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary plasma cell leukemia in the era of novel agents for myeloma - a multicenter retrospective analysis of outcome.
    Ganzel C; Rouvio O; Avivi I; Magen H; Jarchowsky O; Herzog K; Cohen Y; Tadmor T; Horwitz NA; Leiba M; Nagler A; Cohen Y; Bulvik S; Polliack A; Rowe JM; Gatt ME;
    Leuk Res; 2018 May; 68():9-14. PubMed ID: 29501828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias.
    Gavriatopoulou M; Musto P; Caers J; Merlini G; Kastritis E; van de Donk N; Gay F; Hegenbart U; Hajek R; Zweegman S; Bruno B; Straka C; Dimopoulos MA; Einsele H; Boccadoro M; Sonneveld P; Engelhardt M; Terpos E
    Leukemia; 2018 Sep; 32(9):1883-1898. PubMed ID: 30038381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical characteristics of patients with primary plasma cell leukemia and the efficacy of novel agents and hematopoietic stem cell transplantation].
    Li WJ; Wang FR; Wen L; Chen Y; Chen H; Huang XJ; Lu J
    Zhonghua Nei Ke Za Zhi; 2020 Oct; 59(10):801-806. PubMed ID: 32987483
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and cytogenetic characteristics of primary and secondary plasma cell leukemia under the new IMWG definition criteria: a retrospective study.
    Guan J; Ma J; Chen B
    Hematology; 2023 Dec; 28(1):2254556. PubMed ID: 37732631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary plasma cell leukemia in the era of new drugs: has something changed?
    Musto P; Pagano L; Petrucci MT; Morabito F; Caravita T; Di Raimondo F; Baldini L; Tosi P; Bringhen S; Offidani M; Omede' P; Neri A; D'Auria F; Bochicchio GB; Cavo M; Boccadoro M; Palumbo A
    Crit Rev Oncol Hematol; 2012 May; 82(2):141-9. PubMed ID: 21719304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myélome.
    Royer B; Minvielle S; Diouf M; Roussel M; Karlin L; Hulin C; Arnulf B; Macro M; Cailleres S; Brion A; Brechignac S; Belhadj K; Chretien ML; Wetterwald M; Chaleteix C; Tiab M; Leleu X; Frenzel L; Garderet L; Choquet S; Fuzibet JG; Dauriac C; Forneker LM; Benboubker L; Facon T; Moreau P; Avet-Loiseau H; Marolleau JP
    J Clin Oncol; 2016 Jun; 34(18):2125-32. PubMed ID: 27114594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary plasma cell leukemia presenting as a thoracic mass.
    Igala M; Bopaka RG; Khtabi W; Benchekroun S; Quessar A
    Pan Afr Med J; 2014; 19():39. PubMed ID: 25667701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple myeloma patients with low proportion of circulating plasma cells had similar survival with primary plasma cell leukemia patients.
    An G; Qin X; Acharya C; Xu Y; Deng S; Shi L; Zang M; Sui W; Yi S; Li Z; Hao M; Feng X; Jin F; Zou D; Qi J; Zhao Y; Tai YT; Wang J; Qiu L
    Ann Hematol; 2015 Feb; 94(2):257-64. PubMed ID: 25231928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.